Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Effect of Ivospemin and Difluoromethylornithine Polyamine Inhibitors on Viability of Myeloma Cell Lines

Abdur Rehman, Lubna Rehman, Krish Devnani, Cao Cuong Le, Chun-Yen Lin, Xiayoun Cheng, Fuliang Chu, Jinsheng Weng, Jingwei Liu, Sridevi Patchva, Shao-Qing Kuang, Jingjing Cao, Matthew Richard, Elizabeth Bruckheimer, Sattva S. Neelapu, Neeraj Y. Saini

Blood (2023) 142 (Supplement 1): 6589.

https://doi.org/10.1182/blood-2023-189595

Published: 2023

Journal Articles

Targeting B-Cell Malignancies with Anti-ROR1 CAR T-Cell Therapy

Jinsheng Weng, Cao Cuong Le, Yong Pan, Francesca Perutelli, Xiaoyun Cheng, Jingjing Cao, Owhofasa Agbedia, Shao-Qing Kuang, Jingwei Liu, Fuliang Chu, Sridevi Patchva, Neeraj Y. Saini, Sattva S. Neelapu

Blood (2023) 142 (Supplement 1): 6827.

https://doi.org/10.1182/blood-2023-180028

Published: 2023

Journal Articles

Development of a Novel Platform for in-Vitro Immune-Monitoring of Antigen-Specific T Cells and Discovery of Novel Antigen-Specific TCRs Using Immortalized B Cells Transfected with mRNA of Antigen Fused to Mitd (IBMAM)

Tiantian Zhang, Zhe Wang, Soung-chul Cha, Aaron Anderson, Jingwei Liu, Zhenyuan Dong, Szymon Szymura, Benjamin Kuang, Elizabeth Oh, Sattva S. Neelapu, Larry W. Kwak

Blood (2022) 140 (Supplement 1): 4699–4700.

https://doi.org/10.1182/blood-2022-157599

Published: 2022

Journal Articles

Combination Therapy with BTK Inhibitor Plus Anti-PD-1 Antibody Results in a Hyperprogressor Phenotype in a Mouse Model of CLL

Aidi Gu, PhD, Huaxian Ma, MS, Xiaorui Zhang, BS, Prerna Malaney, PhD, Miguel Gallardo, PhD, Jingwei Liu, MD, Sattva S. Neelapu, MD, Sean M Post, PhD

Blood (2018) 132 (Supplement 1): 4416.

https://doi.org/10.1182/blood-2018-99-118773

Published: 2018

Journal Articles

Targeting CAR T Resistance Due to CD19 Loss with CD79b-Specific CAR T Cells in B-Cell Malignancies

Fuliang Chu, PhD, Jinsheng Weng, MD PhD, Shao-Qing Kuang, PhD, Xiaoyun Cheng, JingJing Cao, Jingwei Liu, MD, Swathi Karri, Adithi Reddy, Sattva S. Neelapu, MD

Blood (2018) 132 (Supplement 1): 1662.

https://doi.org/10.1182/blood-2018-99-119009

Published: 2018

NARROW

Effect of Ivospemin and Difluoromethylornithine Polyamine Inhibitors on Viability of Myeloma Cell Lines

Targeting B-Cell Malignancies with Anti-ROR1 CAR T-Cell Therapy

Development of a Novel Platform for in-Vitro Immune-Monitoring of Antigen-Specific T Cells and Discovery of Novel Antigen-Specific TCRs Using Immortalized B Cells Transfected with mRNA of Antigen Fused to Mitd (IBMAM)

Combination Therapy with BTK Inhibitor Plus Anti-PD-1 Antibody Results in a Hyperprogressor Phenotype in a Mouse Model of CLL

Targeting CAR T Resistance Due to CD19 Loss with CD79b-Specific CAR T Cells in B-Cell Malignancies

Email alerts

ASH Publications

American Society of Hematology

Effect of Ivospemin and Difluoromethylornithine Polyamine Inhibitors on Viability of Myeloma Cell Lines

Targeting B-Cell Malignancies with Anti-ROR1 CAR T-Cell Therapy

Development of a Novel Platform for in-Vitro Immune-Monitoring of Antigen-Specific T Cells and Discovery of Novel Antigen-Specific TCRs Using Immortalized B Cells Transfected with mRNA of Antigen Fused to Mitd (IBMAM)

Combination Therapy with BTK Inhibitor Plus Anti-PD-1 Antibody Results in a Hyperprogressor Phenotype in a Mouse Model of CLL

Targeting CAR T Resistance Due to CD19 Loss with CD79b-Specific CAR T Cells in B-Cell Malignancies

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only